Core Laboratories N.V.
CLBNYSEEnergy● Active
$13.43
+$0.50(+3.87%)
Market Cap$619078439
P/E Ratio—
52W High$20.36
52W Low$9.72
Core Laboratories N.V. (CLB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.53B | $0.52B | $0.51B | $0.49B | $0.47B |
| Cost of Revenue | $0.43B | $0.44B | $0.42B | $0.41B | $0.39B |
| Gross Profit | $0.09B | $0.09B | $0.09B | $0.08B | $0.08B |
| Gross Margin %(computed) | 17.91% | 16.87% | 18.45% | 16.11% | 17.83% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.04B | $0.04B | $0.04B | $0.04B | $0.04B |
| Total Operating Expenses | $0.04B | $0.03B | $0.04B | $0.04B | $0.04B |
| Operating Income | $0.05B | $0.06B | $0.05B | $0.04B | $0.05B |
| Operating Margin %(computed) | 9.59% | 11.18% | 10.72% | 8.48% | 9.63% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.05B | $0.05B | $0.04B | $0.03B | $0.04B |
| Income Tax Expense | $0.02B | $0.01B | $0.00B | $0.01B | $0.02B |
| Net Income | $0.03B | $0.03B | $0.04B | $0.02B | $0.02B |
| Net Margin %(computed) | 5.63% | 5.99% | 7.19% | 3.97% | 4.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.68 | $0.67 | $0.79 | $0.42 | $0.43 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | $0.07B | $0.07B | $0.07B | $0.06B | $0.06B |
| EBITDA Margin %(computed) | 13.51% | 13.99% | 13.81% | 11.98% | 13.56% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Core Laboratories N.V. data
About Core Laboratories N.V. (CLB) Income Statement
Core Laboratories N.V. (CLB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CLB reported revenue of $0.53B, gross profit of $0.09B (gross margin 17.91%), and net income of $0.03B — a net profit margin of 5.63%.
Frequently asked questions
CLB · 4 questionsCore Laboratories N.V. (CLB) reported revenue of $0.53B for 2025, up 0.5% year-over-year.
CLB revenueCLB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08